Allianz Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28M | Buy |
128,600
+25,900
| +25% | +$5.75M | 0.03% | 518 |
|
|
2025
Q4 | $23.5M | Sell |
102,700
-13,100
| -11% | -$2.98M | 0.02% | 534 |
|
|
2025
Q3 | $26.8M | Buy |
115,800
+13,800
| +14% | +$2.81M | 0.03% | 487 |
|
|
2025
Q2 | $18.9M | Sell |
102,000
-20,600
| -17% | -$3.83M | 0.02% | 590 |
|
|
2025
Q1 | $25.7M | Buy |
122,600
+10,100
| +9% | +$1.96M | 0.03% | 498 |
|
|
2024
Q4 | $20M | Sell |
112,500
-4,100
| -4% | -$754K | 0.03% | 545 |
|
|
2024
Q3 | $23M | Buy |
116,600
+43,500
| +60% | +$8.12M | 0.03% | 504 |
|
|
2024
Q2 | $12.5M | Buy |
73,100
+63,000
| +624% | +$10.4M | 0.02% | 633 |
|
|
2024
Q1 | $1.84M | Sell |
10,100
-144,600
| -93% | -$24.9M | ﹤0.01% | 1207 |
|
|
2023
Q4 | $24M | Sell |
154,700
-107,400
| -41% | -$15.7M | 0.04% | 418 |
|
|
2023
Q3 | $39.1M | Buy |
262,100
+10,900
| +4% | +$1.6M | 0.07% | 308 |
|
|
2023
Q2 | $33.8M | Buy |
251,200
+134,900
| +116% | +$19.8M | 0.06% | 311 |
|
|
2023
Q1 | $18.5M | Buy |
116,300
+41,300
| +55% | +$6.31M | 0.03% | 499 |
|
|
2022
Q4 | $12.1M | Buy |
75,000
+31,800
| +74% | +$4.88M | 0.02% | 622 |
|
|
2022
Q3 | $5.8M | Buy |
43,200
+19,900
| +85% | +$2.86M | 0.01% | 836 |
|
|
2022
Q2 | $3.57M | Sell |
23,300
-143,800
| -86% | -$22M | ﹤0.01% | 1216 |
|
|
2022
Q1 | $27.1M | Buy |
167,100
+77,700
| +87% | +$11.3M | 0.02% | 651 |
|
|
2021
Q4 | $12.1M | Sell |
89,400
-34,500
| -28% | -$4.08M | 0.01% | 927 |
|
|
2021
Q3 | $13.4M | Buy |
123,900
+68,200
| +122% | +$7.79M | 0.01% | 886 |
|
|
2021
Q2 | $6.27M | Buy |
55,700
+7,000
| +14% | +$788K | 0.01% | 1011 |
|
|
2021
Q1 | $5.27M | Buy |
+48,700
| New | +$5.21M | 0.01% | 1045 |
|
|
2020
Q3 | – | Sell |
-302,700
| Closed | -$29.7M | – | 1835 |
|
|
2020
Q2 | $29.7M | Buy |
302,700
+102,000
| +51% | +$8.98M | 0.03% | 485 |
|
|
2020
Q1 | $15.3M | Sell |
200,700
-173,400
| -46% | -$14.8M | 0.02% | 661 |
|
|
2019
Q4 | $33.1M | Buy |
374,100
+11,500
| +3% | +$955K | 0.03% | 560 |
|
|
2019
Q3 | $27.5M | Sell |
362,600
-12,700
| -3% | -$871K | 0.03% | 649 |
|
|
2019
Q2 | $27.3M | Sell |
375,300
-20,400
| -5% | -$1.6M | 0.03% | 663 |
|
|
2019
Q1 | $31.9M | Sell |
395,700
-225,900
| -36% | -$18.5M | 0.03% | 563 |
|
|
2018
Q4 | $57.3M | Sell |
621,600
-153,100
| -20% | -$13.5M | 0.06% | 330 |
|
|
2018
Q3 | $73.3M | Sell |
774,700
-154,400
| -17% | -$14.6M | 0.07% | 322 |
|
|
2018
Q2 | $86.1M | Buy |
929,100
+34,100
| +4% | +$3.33M | 0.08% | 263 |
|
|
2018
Q1 | $84.7M | Sell |
895,000
-1,600,800
| -64% | -$176M | 0.08% | 272 |
|
|
2017
Q4 | $241M | Buy |
2,495,800
+190,600
| +8% | +$18M | 0.19% | 96 |
|
|
2017
Q3 | $205M | Buy |
2,305,200
+539,100
| +31% | +$41M | 0.18% | 106 |
|
|
2017
Q2 | $128M | Buy |
1,766,100
+112,200
| +7% | +$7.54M | 0.12% | 187 |
|
|
2017
Q1 | $108M | Sell |
1,653,900
-859,200
| -34% | -$54M | 0.11% | 213 |
|
|
2016
Q4 | $157M | Buy |
2,513,100
+868,400
| +53% | +$53M | 0.14% | 157 |
|
|
2016
Q3 | $104M | Buy |
1,644,700
+64,300
| +4% | +$4.16M | 0.1% | 213 |
|
|
2016
Q2 | $97.8M | Buy |
1,580,400
+1,032,000
| +188% | +$62.9M | 0.1% | 211 |
|
|
2016
Q1 | $31.3M | Buy |
548,400
+25,000
| +5% | +$1.39M | 0.04% | 557 |
|
|
2015
Q4 | $31M | Buy |
523,400
+141,600
| +37% | +$8.16M | 0.04% | 564 |
|
|
2015
Q3 | $20.8M | Sell |
381,800
-273,100
| -42% | -$17.8M | 0.02% | 691 |
|
|
2015
Q2 | $44M | Buy |
654,900
+246,900
| +61% | +$16.1M | 0.05% | 479 |
|
|
2015
Q1 | $23.9M | Sell |
408,000
-81,400
| -17% | -$4.92M | 0.03% | 625 |
|
|
2014
Q4 | $32M | Buy |
489,400
+310,100
| +173% | +$19.5M | 0.04% | 539 |
|
|
2014
Q3 | $10.4M | Buy |
+179,300
| New | +$9.95M | 0.01% | 825 |
|
Other funds holding ABBV
VCM
VPM
Allianz Asset Management's ABBV Position: Q1 2026 in Review
Allianz Asset Management increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $29.9M and bringing the position to 1,393,938 shares worth $303M. The position accounts for 0.32% of the portfolio, ranked #61.
Allianz Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $863M in Q2 2015. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Allianz Asset Management held 1,393,938 shares of AbbVie worth $303M as of Q1 2026.
- Allianz Asset Management bought 134,715 AbbVie shares in Q1 2026, an estimated $29.9M.
- AbbVie made up 0.32% of Allianz Asset Management's portfolio in Q1 2026, its #61 holding.
- Allianz Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's AbbVie position peaked at $863M in Q2 2015.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.